Clinical Trial Update: A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate BioChaperone PDGF-BB for treating chronic diabetic foot ulcers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• BioChaperone PDGF-BB (platelet-derived growth factor BB)

Snippet

Sponsor: Adocia | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: COMPLETED